The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
DNA	NN	I-NP	O	Other	###	2	DNA	DNA	NN	NN	_	13	nsubjpass	_	_
and	CC	I-NP	O	Other	###	3	and	and	CC	CC	_	2	cc	_	_
steroid	NN	I-NP	B-protein	Other	###	4	steroid	steroid	NN	NN	_	6	compound	_	_
binding	NN	I-NP	I-protein	Other	###	5	binding	binding	NN	NN	_	6	compound	_	_
domains	NNS	I-NP	I-protein	Other	###	6	domains	domains	NNS	NNS	_	2	conj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	10	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	9	glucocorticoid	glucocorticoid	NN	NN	_	10	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	10	receptor	receptor	NN	NN	_	2	nmod	_	_
are	VBP	B-VP	O	Other	###	11	are	are	VBP	VBP	_	13	auxpass	_	_
not	RB	I-VP	O	Other	###	12	not	not	RB	RB	_	13	neg	_	_
altered	VBN	I-VP	O	Other	###	13	altered	altered	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	16	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	###	15	mononuclear	mononuclear	JJ	JJ	_	16	amod	_	_
cells	NNS	I-NP	I-cell_type	Other	###	16	cells	cells	NNS	NNS	_	13	nmod	_	_
of	IN	B-PP	O	Other	###	17	of	of	IN	IN	_	20	case	_	_
treated	VBN	B-NP	O	Other	###	18	treated	treated	VBN	VBN	_	20	amod	_	_
CLL	NN	I-NP	O	Other	###	19	CLL	CLL	NN	NN	_	20	compound	_	_
patients	NNS	I-NP	O	Other	###	20	patients	patients	NNS	NNS	_	16	nmod	_	_
.	.	O	O	Other	###	21	.	.	.	.	_	13	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
aim	NN	I-NP	O	Other	###	2	aim	aim	NN	NN	_	6	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	5	case	_	_
this	DT	B-NP	O	Other	###	4	this	this	DT	DT	_	5	det	_	_
study	NN	I-NP	O	Other	###	5	study	study	NN	NN	_	2	nmod	_	_
was	VBD	B-VP	O	Other	###	6	was	was	VBD	VBD	_	0	root	_	_
to	TO	B-VP	O	Other	###	7	to	to	TO	TO	_	8	mark	_	_
investigate	VB	I-VP	O	Other	###	8	investigate	investigate	VB	VB	_	6	xcomp	_	_
whether	IN	B-SBAR	O	Other	###	9	whether	whether	IN	IN	_	16	mark	_	_
mutations	NNS	B-NP	O	Other	###	10	mutations	mutations	NNS	NNS	_	16	nsubj	_	_
in	IN	B-PP	O	Other	###	11	in	in	IN	IN	_	14	case	_	_
the	DT	B-NP	O	Other	###	12	the	the	DT	DT	_	14	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	13	glucocorticoid	glucocorticoid	NN	NN	_	14	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	14	receptor	receptor	NN	NN	_	10	nmod	_	_
could	MD	B-VP	O	Other	###	15	could	could	MD	MD	_	16	aux	_	_
account	VB	I-VP	O	Other	###	16	account	account	VB	VB	_	8	ccomp	_	_
for	IN	B-PP	O	Other	###	17	for	for	IN	IN	_	20	case	_	_
the	DT	B-NP	O	Other	###	18	the	the	DT	DT	_	20	det	_	_
increasing	VBG	I-NP	O	Other	###	19	increasing	increasing	VBG	VBG	_	20	amod	_	_
unresponsiveness	NN	I-NP	O	Other	###	20	unresponsiveness	unresponsiveness	NN	NN	_	16	nmod	_	_
of	IN	B-PP	O	Other	###	21	of	of	IN	IN	_	22	case	_	_
patients	NNS	B-NP	O	Other	###	22	patients	patients	NNS	NNS	_	20	nmod	_	_
with	IN	B-PP	O	Other	###	23	with	with	IN	IN	_	26	case	_	_
chronic	JJ	B-NP	O	Other	###	24	chronic	chronic	JJ	JJ	_	26	amod	_	_
lymphatic	JJ	I-NP	O	Other	###	25	lymphatic	lymphatic	JJ	JJ	_	26	amod	_	_
leukemia	NN	I-NP	O	Other	###	26	leukemia	leukemia	NN	NN	_	22	nmod	_	_
(	(	O	O	Other	###	27	(	(	(	(	_	28	punct	_	_
CLL	NN	B-NP	O	Other	###	28	CLL	CLL	NN	NN	_	26	appos	_	_
)	)	O	O	Other	###	29	)	)	)	)	_	28	punct	_	_
to	TO	B-PP	O	Other	###	30	to	to	TO	TO	_	32	case	_	_
combination	NN	B-NP	O	Other	###	31	combination	combination	NN	NN	_	32	compound	_	_
chemotherapy	NN	I-NP	O	Other	###	32	chemotherapy	chemotherapy	NN	NN	_	20	nmod	_	_
.	.	O	O	Other	###	33	.	.	.	.	_	6	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
receptor	NN	I-NP	O	Other	###	2	receptor	receptor	NN	NN	_	4	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	3	was	was	VBD	VBD	_	4	auxpass	_	_
tested	VBN	I-VP	O	Other	###	4	tested	tested	VBN	VBN	_	0	root	_	_
immunocytochemically	RB	B-ADVP	O	Other	###	5	immunocytochemically	immunocytochemically	RB	RB	_	12	advmod	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	12	punct	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	10	case	_	_
steroid	NN	B-NP	O	Other	###	8	steroid	steroid	NN	NN	_	10	compound	_	_
binding	NN	I-NP	O	Other	###	9	binding	binding	NN	NN	_	10	compound	_	_
assays	NNS	I-NP	O	Other	###	10	assays	assays	NNS	NNS	_	12	conj	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	12	punct	_	_
and	CC	O	O	Other	###	12	and	and	CC	CC	_	4	advmod	_	_
by	IN	B-PP	O	Other	###	13	by	by	IN	IN	_	16	case	_	_
a	DT	B-NP	O	Other	###	14	a	a	DT	DT	_	16	det	_	_
mutation	NN	I-NP	O	Other	###	15	mutation	mutation	NN	NN	_	16	compound	_	_
screening	NN	I-NP	O	Other	###	16	screening	screening	NN	NN	_	12	conj	_	_
(	(	O	O	Other	###	17	(	(	(	(	_	18	punct	_	_
denaturing	VBG	B-VP	O	Other	###	18	denaturing	denaturing	VBG	VBG	_	16	dep	_	_
gradient	NN	B-NP	O	Other	###	19	gradient	gradient	NN	NN	_	21	compound	_	_
gel	NN	I-NP	O	Other	###	20	gel	gel	NN	NN	_	21	compound	_	_
electrophoresis	NN	I-NP	O	Other	###	21	electrophoresis	electrophoresis	NN	NN	_	18	dobj	_	_
)	)	O	O	Other	###	22	)	)	)	)	_	18	punct	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	27	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	27	det	_	_
receptor	NN	I-NP	B-protein	Other	###	25	receptor	receptor	NN	NN	_	27	compound	_	_
-	-	O	O	Other	###	26	-	-	-	-	_	27	punct	_	_
cDNA	NN	I-NP	B-protein	Other	###	27	cDNA	cDNA	NN	NN	_	16	nmod	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	4	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	3	det	_	_
receptor	NN	I-NP	O	Other	###	2	receptor	receptor	NN	NN	_	3	compound	_	_
concentration	NN	I-NP	O	Other	###	3	concentration	concentration	NN	NN	_	14	nsubj	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	3	punct	_	_
as	IN	B-SBAR	O	Other	###	5	as	as	IN	IN	_	6	mark	_	_
measured	VBN	B-VP	O	Other	###	6	measured	measured	VBN	VBN	_	14	dep	_	_
by	IN	B-PP	O	Other	###	7	by	by	IN	IN	_	8	case	_	_
staining	NN	B-NP	O	Other	###	8	staining	staining	NN	NN	_	6	nmod	_	_
and	CC	I-NP	O	Other	###	9	and	and	CC	CC	_	8	cc	_	_
steroid	NN	I-NP	O	Other	###	10	steroid	steroid	NN	NN	_	12	compound	_	_
binding	NN	I-NP	O	Other	###	11	binding	binding	NN	NN	_	12	compound	_	_
test	NN	I-NP	O	Other	###	12	test	test	NN	NN	_	8	conj	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	14	punct	_	_
varied	VBD	B-VP	O	Other	###	14	varied	varied	VBD	VBD	_	0	root	_	_
considerably	RB	B-ADVP	O	Other	###	15	considerably	considerably	RB	RB	_	14	advmod	_	_
but	CC	O	O	Other	###	16	but	but	CC	CC	_	14	cc	_	_
showed	VBD	B-VP	O	Other	###	17	showed	showed	VBD	VBD	_	14	conj	_	_
no	DT	B-NP	O	Other	###	18	no	no	DT	DT	_	20	neg	_	_
clear	JJ	I-NP	O	Other	###	19	clear	clear	JJ	JJ	_	20	amod	_	_
correlation	NN	I-NP	O	Other	###	20	correlation	correlation	NN	NN	_	17	dobj	_	_
to	TO	B-PP	O	Other	###	21	to	to	TO	TO	_	23	case	_	_
clinical	JJ	B-NP	O	Other	###	22	clinical	clinical	JJ	JJ	_	23	amod	_	_
response	NN	I-NP	O	Other	###	23	response	response	NN	NN	_	20	nmod	_	_
.	.	O	O	Other	###	24	.	.	.	.	_	14	punct	_	_

Using	VBG	B-VP	O	Other	###	1	Using	Using	VBG	VBG	_	0	root	_	_
a	DT	B-NP	O	Other	###	2	a	a	DT	DT	_	7	det	_	_
highly	RB	I-NP	O	Other	###	3	highly	highly	RB	RB	_	4	advmod	_	_
sensitive	JJ	I-NP	O	Other	###	4	sensitive	sensitive	JJ	JJ	_	7	amod	_	_
mutation	NN	I-NP	O	Other	###	5	mutation	mutation	NN	NN	_	7	compound	_	_
screening	NN	I-NP	O	Other	###	6	screening	screening	NN	NN	_	7	compound	_	_
assay	NN	I-NP	O	Other	###	7	assay	assay	NN	NN	_	1	dobj	_	_
of	IN	B-PP	O	Other	###	8	of	of	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	10	det	_	_
DNA	NN	I-NP	O	Other	###	10	DNA	DNA	NN	NN	_	7	nmod	_	_
-	-	O	O	Other	###	11	-	-	-	-	_	10	punct	_	_
and	CC	O	O	Other	###	12	and	and	CC	CC	_	10	cc	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	17	det	_	_
steroid	JJ	I-NP	B-DNA	Other	###	14	steroid	steroid	JJ	JJ	_	17	amod	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	17	punct	_	_
binding	JJ	I-NP	B-DNA	Other	###	16	binding	binding	JJ	JJ	_	17	amod	_	_
region	NN	I-NP	I-DNA	Other	###	17	region	region	NN	NN	_	10	conj	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	1	punct	_	_
none	NN	B-NP	O	Other	###	19	none	none	NN	NN	_	24	nsubj	_	_
of	IN	B-PP	O	Other	###	20	of	of	IN	IN	_	23	case	_	_
the	DT	B-NP	O	Other	###	21	the	the	DT	DT	_	23	det	_	_
treated	VBN	I-NP	O	Other	###	22	treated	treated	VBN	VBN	_	23	amod	_	_
patients	NNS	I-NP	O	Other	###	23	patients	patients	NNS	NNS	_	19	nmod	_	_
revealed	VBD	B-VP	O	Other	###	24	revealed	revealed	VBD	VBD	_	1	parataxis	_	_
any	DT	B-NP	O	Other	###	25	any	any	DT	DT	_	26	det	_	_
mutation	NN	I-NP	O	Other	###	26	mutation	mutation	NN	NN	_	24	dobj	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	24	punct	_	_
suggesting	VBG	B-VP	O	Other	###	28	suggesting	suggesting	VBG	VBG	_	24	advcl	_	_
that	IN	B-SBAR	O	Other	###	29	that	that	IN	IN	_	40	mark	_	_
the	DT	B-NP	O	Other	###	30	the	the	DT	DT	_	32	det	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	31	glucocorticoid	glucocorticoid	NN	NN	_	32	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	32	receptor	receptor	NN	NN	_	40	nsubjpass	_	_
in	IN	B-PP	O	Other	###	33	in	in	IN	IN	_	36	case	_	_
the	DT	B-NP	O	Other	###	34	the	the	DT	DT	_	36	det	_	_
CLL	NN	I-NP	O	Other	###	35	CLL	CLL	NN	NN	_	36	compound	_	_
patients	NNS	I-NP	O	Other	###	36	patients	patients	NNS	NNS	_	32	nmod	_	_
tested	VBN	B-VP	O	Other	###	37	tested	tested	VBN	VBN	_	36	acl	_	_
is	VBZ	B-VP	O	Other	###	38	is	is	VBZ	VBZ	_	40	auxpass	_	_
not	RB	I-VP	O	Other	###	39	not	not	RB	RB	_	40	neg	_	_
altered	VBN	I-VP	O	Other	###	40	altered	altered	VBN	VBN	_	28	ccomp	_	_
in	IN	B-PP	O	Other	###	41	in	in	IN	IN	_	43	case	_	_
these	DT	B-NP	O	Other	###	42	these	these	DT	DT	_	43	det	_	_
domains	NNS	I-NP	O	Other	###	43	domains	domains	NNS	NNS	_	40	nmod	_	_
.	.	O	O	Other	###	44	.	.	.	.	_	1	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
one	CD	B-NP	O	Other	###	2	one	one	CD	CD	_	3	nummod	_	_
individual	NN	I-NP	O	Other	###	3	individual	individual	NN	NN	_	15	nmod	_	_
who	WP	B-NP	O	Other	###	4	who	who	WP	WP	_	8	nsubjpass	_	_
had	VBD	B-VP	O	Other	###	5	had	had	VBD	VBD	_	8	aux	_	_
not	RB	I-VP	O	Other	###	6	not	not	RB	RB	_	8	neg	_	_
been	VBN	I-VP	O	Other	###	7	been	been	VBN	VBN	_	8	auxpass	_	_
treated	VBN	I-VP	O	Other	###	8	treated	treated	VBN	VBN	_	3	acl:relcl	_	_
before	IN	B-PP	O	Other	###	9	before	before	IN	IN	_	10	case	_	_
analysis	NN	B-NP	O	Other	###	10	analysis	analysis	NN	NN	_	8	nmod	_	_
a	DT	B-NP	O	Other	###	11	a	a	DT	DT	_	13	det	_	_
silent	JJ	I-NP	O	Other	###	12	silent	silent	JJ	JJ	_	13	amod	_	_
mutation	NN	I-NP	O	Other	###	13	mutation	mutation	NN	NN	_	15	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	14	was	was	VBD	VBD	_	15	auxpass	_	_
found	VBN	I-VP	O	Other	###	15	found	found	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	16	in	in	IN	IN	_	19	case	_	_
one	CD	B-NP	O	Other	###	17	one	one	CD	CD	_	19	nummod	_	_
receptor	NN	I-NP	O	Other	###	18	receptor	receptor	NN	NN	_	19	compound	_	_
allele	NN	I-NP	O	Other	###	19	allele	allele	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	15	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
results	NNS	I-NP	O	Other	###	2	results	results	NNS	NNS	_	3	nsubj	_	_
suggest	VBP	B-VP	O	Other	###	3	suggest	suggest	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	4	that	that	IN	IN	_	18	mark	_	_
mechanisms	NNS	B-NP	O	Other	###	5	mechanisms	mechanisms	NNS	NNS	_	18	nsubj	_	_
other	JJ	B-ADJP	O	Other	###	6	other	other	JJ	JJ	_	5	cc	_	_
than	IN	B-PP	O	Other	###	7	than	than	IN	IN	_	6	dep	_	_
altered	JJ	B-NP	O	Other	###	8	altered	altered	JJ	JJ	_	9	amod	_	_
ligand	NN	I-NP	O	Other	###	9	ligand	ligand	NN	NN	_	5	conj	_	_
or	CC	I-NP	O	Other	###	10	or	or	CC	CC	_	9	cc	_	_
DNA	NN	I-NP	O	Other	###	11	DNA	DNA	NN	NN	_	12	compound	_	_
binding	NN	I-NP	O	Other	###	12	binding	binding	NN	NN	_	9	conj	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	###	14	the	the	DT	DT	_	15	det	_	_
receptor	NN	I-NP	O	Other	###	15	receptor	receptor	NN	NN	_	12	nmod	_	_
may	MD	B-VP	O	Other	###	16	may	may	MD	MD	_	18	aux	_	_
be	VB	I-VP	O	Other	###	17	be	be	VB	VB	_	18	cop	_	_
responsible	JJ	B-ADJP	O	Other	###	18	responsible	responsible	JJ	JJ	_	3	ccomp	_	_
for	IN	B-PP	O	Other	###	19	for	for	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	21	det	_	_
lack	NN	I-NP	O	Other	###	21	lack	lack	NN	NN	_	18	nmod	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	23	case	_	_
response	NN	B-NP	O	Other	###	23	response	response	NN	NN	_	21	nmod	_	_
to	TO	B-PP	O	Other	###	24	to	to	TO	TO	_	25	case	_	_
chemotherapy	NN	B-NP	O	Other	###	25	chemotherapy	chemotherapy	NN	NN	_	23	nmod	_	_
.	.	O	O	Other	###	26	.	.	.	.	_	3	punct	_	_

This	DT	B-NP	O	Other	###	1	This	This	DT	DT	_	2	det	_	_
conclusion	NN	I-NP	O	Other	###	2	conclusion	conclusion	NN	NN	_	4	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	3	is	is	VBZ	VBZ	_	4	auxpass	_	_
discussed	VBN	I-VP	O	Other	###	4	discussed	discussed	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	5	in	in	IN	IN	_	6	case	_	_
relation	NN	B-NP	O	Other	###	6	relation	relation	NN	NN	_	4	nmod	_	_
to	TO	B-PP	O	Other	###	7	to	to	TO	TO	_	9	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	9	det	_	_
mechanism	NN	I-NP	O	Other	###	9	mechanism	mechanism	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	###	10	of	of	IN	IN	_	12	case	_	_
corticoid	NN	B-NP	O	Other	###	11	corticoid	corticoid	NN	NN	_	12	compound	_	_
resistance	NN	I-NP	O	Other	###	12	resistance	resistance	NN	NN	_	9	nmod	_	_
in	IN	B-PP	O	Other	###	13	in	in	IN	IN	_	18	case	_	_
mouse	NN	B-NP	B-cell_line	Other	###	14	mouse	mouse	NN	NN	_	12	nmod	_	_
and	CC	O	I-cell_line	Other	###	15	and	and	CC	CC	_	14	cc	_	_
human	JJ	B-NP	I-cell_line	Other	###	16	human	human	JJ	JJ	_	14	conj	_	_
lymphoma	NN	I-NP	I-cell_line	Other	###	17	lymphoma	lymphoma	NN	NN	_	18	compound	_	_
cells	NNS	I-NP	I-cell_line	Other	###	18	cells	cells	NNS	NNS	_	14	dep	_	_
in	IN	B-PP	O	Other	###	19	in	in	IN	IN	_	20	case	_	_
culture	NN	B-NP	O	Other	###	20	culture	culture	NN	NN	_	18	nmod	_	_
.	.	O	O	Other	###	21	.	.	.	.	_	4	punct	_	_

